创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: What are the features of the iHuPBMC-NK platform?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-25 10:24
  • Views:

(Summary description)Among the many components of the immune system, natural killer (NK) cells have attracted much attention for their unique non-specific killing ability and rapid response mechanism. The iHuPBMC-NK platform launched by InnoModels Biotechnology is designed for in-depth study of the functions and applications of NK cells. The platform integrates a number of advanced technologies with distinctive features and plays an important role in NK cell research

InnoModels Biotechnology: What are the features of the iHuPBMC-NK platform?

(Summary description)Among the many components of the immune system, natural killer (NK) cells have attracted much attention for their unique non-specific killing ability and rapid response mechanism. The iHuPBMC-NK platform launched by InnoModels Biotechnology is designed for in-depth study of the functions and applications of NK cells. The platform integrates a number of advanced technologies with distinctive features and plays an important role in NK cell research

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-03-25 10:24
  • Views:
Information

Among the many components of the immune system, natural killer (NK) cells have attracted much attention for their unique non-specific killing ability and rapid response mechanism. The iHuPBMC-NK platform launched by InnoModels Biotechnology is designed for in-depth study of the functions and applications of NK cells. The platform integrates a number of advanced technologies with distinctive features and plays an important role in NK cell research.
1、Highly simulates the human environment
The iHuPBMC-NK platform adopts a humanized peripheral blood single nucleated cell (PBMC) system, which contains not only NK cells, but also a rich variety of other immune cell types, which greatly improves the physiological relevance and accuracy of the experiments. By simulating the complex microenvironment in the human body, the platform can more realistically reflect the behavior and function of NK cells in vivo.
2. Precise regulation of NK cell activity
The platform has the ability to precisely regulate the activity of NK cells. Researchers can regulate the proliferation, differentiation and activation process of NK cells according to experimental needs, so as to deeply explore the mechanism of NK cells in different physiological and pathological conditions.
3、Promote the development of NK cell therapy
With the rise of immunotherapy, NK cell therapy shows great potential in the fields of cancer, viral infection, etc. The iHuPBMC-NK platform provides strong support for the research of NK cell therapy. Through this platform, researchers can assess the impact of different treatment strategies on NK cell function, optimize treatment plans, and promote NK cell therapy from laboratory to clinical application.

 


4. Powerful data analysis and processing capabilities
The platform is equipped with an advanced data analysis and processing system, which enables comprehensive and in-depth analysis of multiple biological features of NK cells. Through high-throughput sequencing, single-cell sequencing and other technical means, researchers can obtain key information on gene expression, protein interactions, etc. of NK cells, which provides strong support for revealing the complexity of NK cell functions.
5. Easy to operate and reproducible
The iHuPBMC-NK platform is designed to focus on user-friendliness and reproducibility, with easy and fast experimental operation and stable and reliable results. This helps researchers to carry out NK cell-related research quickly and efficiently in busy laboratory work.
In summary, the iHuPBMC-NK platform of InnoModels Biotechnology has become a powerful assistant in the field of NK cell research with its highly simulated human environment, precise regulation of NK cell activity, promotion of NK cell therapy, powerful data analysis and processing capabilities, as well as ease of operation and reproducibility. With the continuous revelation of NK cell function and the advancement of immunotherapy technology, the platform is expected to play an even more important role in the future and make significant contributions to human health.

Keyword:

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司